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Background: The purpose of this study was to examine associations between cardiovascular risk factors and
cognitive ability in middle aged and elderly Lithuanian urban population.
Methods: Data from the survey performed in the framework of the HAPIEE (Health, Alcohol, Psychosocial Factors in
Eastern Europe) study were presented. A random sample of 7,087 individuals aged 45–72 years was screened in
2006–2008.
Results: The scores of immediate recall and delayed verbal recall, cognitive speed and attention were significantly
lower in men than in women; yet numerical ability scores were higher in men. Significant associations between
lowered cognitive functions and previous stroke (in male OR = 2.52; 95% CI = 1.75-3.64; in female OR = 2.45; 95%
CI = 1.75, 3.64) as well as ischemic heart disease history (among male OR = 1.28; 95% CI = 1.03-1.60) have been
determined. Higher level of physical activity in leisure time (among female OR = 1.32; 95% CI = 1.03-1.69), poor
self-rated health (among male OR = 1.57; 95% CI = 1.15-2.14) and poor quality of life (in male OR = 1.67; 95%
CI = 1.07-2.61; in female OR = 2.81; 95% CI = 1.92-4.11) were related to lowered cognitive function.
Conclusions: The findings of the study suggest that associations between cardiovascular risk factors and lowered
cognitive function among healthy middle-aged and elderly adults strongly depend on gender.Background
The ageing of populations worldwide raises concern
regarding the prevalence of cognitive dysfunction in the
future. Cognitive decline and dementia have a high indi-
vidual impact and are strongly age-associated. A consen-
sus report estimated that the number of people with
dementia in the world will increase from 24 million to
82 million from 2000 to 2040 [1]. This increase will be
particularly marked in low and middle income countries
where epidemiological research into the etiology and im-
pact of cognitive impairment is limited. Therefore, it is
becoming increasingly important to identify risk factors
associated with cognitive functions to better target the
preventive strategies and public health messages.* Correspondence: abdonas.tamosiunas@med.kmu.lt
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distribution, and reproduction in any mediumCardiovascular disease (CVD) and cognitive decline
are common problems in middle aged and elderly men
and women [2]. Epidemiological studies have linked cog-
nitive performance with CVD, specific vascular biomar-
kers and risk factors such as cholesterol, hypertension,
diabetes mellitus, fibrinogen levels, homocysteine, C-
reactive protein [3-5] and lifestyle behavior [6,7].
However, the associations are not well established –
researchers have yielded mixed findings. In accordance
with literature sources and given the high levels of mortal-
ity from CVD and unhealthy lifestyles in Lithuania [8-11]
we hypothesized that lowered cognitive functions could be
associated with CVD and its risk factors. The aim of this
study, therefore, was to explore associations between cog-
nitive ability, CVD and its risk factors in middle aged and
elderly Lithuanian urban population.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Study design
Data from the survey performed in the framework of the
international HAPIEE (Health, Alcohol and Psychosocial
Factors in Eastern Europe) study are presented [12]. A
random sample of 10,940 Kaunas (Lithuania) men and
women aged 45–72 years, stratified by gender and age
was selected from Lithuanian population register. The
response rate was 64.8%, thus 7,087 respondents partici-
pated in this health survey from 2006 to 2008. The parti-
cipants were asked at invitation to bring their glasses
and hearing aids, the absence of it was noted. The sub-
jects who were reported that vision/ hearing problems
interfered with their tests were excluded from the ana-
lysis the same as the individuals who refused to finish
some tests. In total 183 responders were excluded from
the statistical analysis because of incomplete informa-
tion. Data from 6,904 subjects (3,129 men and 3,775
women) were approved for statistical analysis. The study
was approved by the Ethics Committee at University
College London, UK and by Kaunas Regional Biomedical
Research Ethics Committee.
Cognitive function
For the purpose of controlling conditions of cognitive
testing, it was executed in a separate consulting room in
the morning. The procedure was administered by spe-
cially trained staff [12]. Cognitive function was assessed
using a battery of five standard tasks, described below.
These tests of cognitive function have been taken from
the English Longitudinal Study of Ageing (ELSA) and
Consortium to Establish a Registry for Alzheimer’s Dis-
ease (CERAD) study [13,14]. Immediate and delayed
verbal memory was assessed using 10-word learning test.
This involved 10 common two-to-four syllable nouns
being presented aurally by tape recorder at the rate of
one word every 2 seconds. The participants were then
asked to recall as many words as possible immediately
and they had two minutes to do so. The test was
repeated three times using the same procedure. The
maximum score of any trial is 10 (range: 0–10). The cu-
mulative total maximum score over all three learning
trials was 30 (range: 0–30). The participants were also
asked to recall as many words as possible again after an
approximately a five-minute delay during which they
completed other cognitive function tests. The maximum
score of delayed verbal memory is 10 (range: 0–10). Se-
mantic verbal fluency was examined by asking the parti-
cipants to name as many animals as possible within 1
minute. Speed and concentration were tested by asking
the participants to cross out as many target letters (‘P’
and ‘W’) as possible within 1 minute, using a sheet with
random letters of the alphabet set out in rows and col-
umns. Numerical ability was assessed using fourquestions involving simple calculations based on every-
day situations. The number of correct responses com-
prised the numeracy score (in the range 0 to 4).
Composite score of cognitive function
Because the scoring of each participant cognitive tests
varies, test scores were standardized to give a mean of 0
and a standard deviation of 1 (z-scores), where high
scores represent high levels of cognitive function. Scores
representing a composite score of cognitive function
were obtained by averaging z-scores in all tests.
Lowered cognitive function
Lowered cognitive function was defined using composite
score of cognitive function. To control for the effect of
age and education on scores, the subjects were stratified
into six age groups and five levels of education. For each
of 30 strata, the mean and SD of the composite score of
cognitive function was calculated. The participants who
scored 1 SD or more below their age and education-
specific means of the composite score of cognitive func-
tion were ascribed to a lowered cognitive function group
[15,16].
Variables determined using the questionnaire
The standard questionnaire included questions regarding
the respondent’s age, education, self-rated health, quality
of life, smoking status, alcohol consumption, physical ac-
tivity, and etc. Education was classified into five educa-
tion levels: primary, vocational, secondary, college and
university. Marital status of all study participants was
divided into five groups: single, married, cohabited,
divorced and widowed. An indicator of material
deprivation was assessed by questions about how often
the person’s household had difficulties in buying enough
food or clothes and paying bills for housing, heating and
electricity. A higher deprivation score means a lower
level of deprivation. Assessment of crowding was based
on the number of inhabitants living in a household. The
respondents were categorized into the following groups
according to their self-rated health and quality of life:
very good, good, average, poor, and very poor.
Smoking habits were assessed according to the current
smoking status. The respondents were classified into
three groups: smokers, former smokers and never smo-
kers. A subject who smoked at least one cigarette per
day was classified as current smoker. Alcohol consump-
tion was measured by asking participants how often they
drank 5 and more alcoholic beverages and how often
they drank less than 5 drinks during the year. Addition-
ally, participants were asked to write how many decili-
ters of different alcoholic beverages (beer, wine, and
spirits) they drank per week. Alcohol consumption was
expressed by amount of absolute alcohol drinks per
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spent per week during leisure time in winter and sum-
mer for walking, moderate and hard work, gardening
and other physical activities. The respondents were cate-
gorized into three groups according to their physical ac-
tivity in leisure time: in men, 1st tercile (0.0-10.5 hours/
week), 2nd tercile (10.61-20.0 hours/week), and 3rd tercile
(> 20.0 hours/week); in women, 1st tercile (0.0-14.0
hours/week), 2nd tercile (14.1-22.5 hours/week), and 3rd
tercile (> 22.5 hours/week).
Depressive symptoms were measured using the 10-
item Center for Epidemiologic Studies Depression Scale
(CES-D 10) [17]. Specially trained personnel filled in
questionnaires by asking interviewing the respondents.
The subjects were asked to evaluate the presence of 10
depressive symptoms during the past week on a two-
point scale: yes or no. Each symptom was scored from 1
(yes) to 0 (no), resulting total score of 0 to 10. The sub-
jects with CES-D 10 scores of 4 or more were classified
as having depressive symptoms.
Measurements
Blood pressure was measured three times, using an
oscillometric device (Omron M5-I) after a five minutes’
rest. The mean of three systolic and diastolic blood pres-
sure was used. Waist circumference was measured by a
standard meter with an accuracy of 0.5 cm. Body mass
index (BMI) was calculated as weight (kg) divided by the
square meters of height.
Laboratory analyses
Biochemical analyses were conducted for participants on
an empty stomach. Concentration of glucose in capillary
blood was determined by an individual glucometer “Glu-
cotrend” [18]. Serum samples were analyzed centrally in
one batch in the WHO Regional Lipid Reference Centre,
Institute of Clinical and Experimental Medicine, Prague
(Czech Republic). Lipid concentrations in serum were
measured, using a conventional enzymatic method.
Definitions of the health conditions
Hypertension was defined as systolic blood pressure ≥
140 mm Hg and/or diastolic blood pressure ≥ 90 mm
Hg, or normal blood pressure (< 140/90 mm Hg) if the
person had taken antihypertensive drugs within the last
two weeks. Metabolic syndrome was defined as the pres-
ence of three or more of five components: systolic/dia-
stolic blood pressure ≥130 and/or 85 mmHg; fasting
plasma glucose ≥6.1 mmol/L; central obesity (waist cir-
cumference >102 cm for men and >88 cm for women);
fasting triglycerides ≥1.7 mmol/L; high density lipopro-
tein (HDL) cholesterol <1.0 mmol/L for men and <1.3
mmol/L for women [19]. Ischemic heart disease (IHD)
was determined by: 1) documented history of myocardialinfarction (MI) and (or) ischemic changes on ECG coded
by the Minnesota codes (MC) 1–1 or 1–2 [20]; 2) angina
pectoris was defined by G. Rose questionnaire (without
MI and (or) MC 1–1 or 1–2; 3) [21]; ECG findings by
MC 1–3, 4–1, 4–2, 4–3, 5–1, 5–2, 5–3, 6–1, 6–2, 7–1,
8–3 (without MI and (or) MC 1–1, 1–2 and without an-
gina pectoris). Diabetes was determined according to the
answers of the respondents to the question “Has a doc-
tor ever told you that you have diabetes?” and/or fasting
glucose level ≥7.8 mmol/L. Stroke was determined using
the question “Has a doctor ever told you that you had a
stroke?”.Statistical analysis
Descriptive statistics (unadjusted and adjusted by age
means and standard errors (SE)) were calculated for
each of the cognitive function tests in gender, age and
education groups. In separate analyses, we examined
age-adjusted means and distribution of various variables
according to the cognitive function in gender groups.
Chi-square (χ2) tests were used for testing association of
various variables with cognitive function (lowered cogni-
tive function vs. normal cognitive function) in gender
groups. Differences in continuous measures between cat-
egories of cognitive function were tested via t-test. Mul-
tiple logistic regression with SPSS version 13.4 software
for windows was used to analyze risk factors associated
with a lowered cognitive function [22]. All independent
variables which were significant in univariate analysis
with the significance level 0.95 (p < 0.05) were then
tested by stepwise backward multiple logistic regression
analysis using the likelihood ratio criterion.Results
The crude and age-adjusted mean scores of specific cog-
nitive function tests and composite scores of cognitive
function for men and women are presented in Table 1.
It is apparent that, unadjusted and age-adjusted means
of immediate and delayed verbal recall, cognitive speed
and attention, composite score of cognitive function
were significantly lower in men than in women. Seman-
tic verbal fluency score was similar in both gender
groups. The mean score of numerical ability was signifi-
cantly higher among men as compared to women.
In additional analyses it was found that the means of
all cognitive functions significantly decreased with age
and, in opposite, they increased with higher education
level among both men and women (p < 0.001).
The prevalence of lowered cognitive function was
20.6% among men and 11.8% among women (p < 0.001).
In both sexes, distribution into groups by cognitive func-
tioning using a composite score as a measure was not
related to age and education due to control for both
Table 1 Cognitive function in Kaunas population by sex, age 45–72 years









Mean ± SE Mean ± SE Mean ± SE Mean ± SE
Immediate verbal recall I 5.45 ± 0.03 6.02 ± 0.03*** 5.46 ± 0.03 6.01 ± 0.02***
Immediate verbal recall II 7.26 ± 0.03 7.90 ± 0.02*** 7.27 ± 0.03 7.89 ± 0.02***
Immediate verbal recall III 8.13 ± 0.03 8.69 ± 0.02*** 8.14 ± 0.03 8.67 ± 0.02***
Immediate verbal recall sum 20.8 ± 0.07 22.6 ± 0.06*** 20.9 ± 0.07 22.6 ± 0.06***
Delayed verbal recall 7.32 ± 0.04 8.02 ± 0.03*** 7.33 ± 0.03 8.01 ± 0.03***
Semantic verbal fluency 21.5 ± 0.11 21.4 ± 0.10 21.5 ± 0.11 21.4 ± 0.10
Numerical ability 3.07 ± 0.01 2.85 ± 0.01*** 3.07 ± 0.01 2.85 ± 0.01***
Cognitive speed and attention 15.4 ± 0.08 16.8 ± 0.08*** 15.5 ± 0.08 16.73 ± 0.07***
Composite score of cognitive function −0.12 ± 0.12 0.1 ± 0.01*** −0.12 ± 0.01 0.1 ± 0.01***
SE - standard error.
***p < 0.001 as compared to men (means were compared using t test).
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tion of variables in cognitive function groups by gender.
Many differences were found between cardiovascular
risk factors and lowered cognitive function due to gen-
der. In men, the means of systolic and diastolic blood
pressure were significantly higher in lowered cognitive
function group than in normal cognitive function group,
yet for women these differences were not significant.
Women with lowered cognitive function had signifi-
cantly higher mean of triglycerides and lower mean of
HDL cholesterol, as compared to women with normal
cognitive function. There were no significant differences
in men scores though. In both sexes LDL cholesterol,
total cholesterol and glucose levels did not differ in low-
ered and normal cognitive function groups. Alcohol in-
take per week was lower in impaired cognitive function
group for women, but not for men. For both sexes
smoking status and body mass index did not differ by
cognitive function groups. However, the mean time
spent for physical activity per week was significantly
higher in normal cognitive function group compared to
lowered cognitive function group among both sexes.
Socioeconomic factors such as crowding and marital sta-
tus did not significantly differ in cognitive functioning
groups, yet deprivation score was lower in lowered cog-
nitive functioning group, which means that higher
deprivation level has a group of lowered cognitive func-
tion as compared with people who better performed
during cognitive functioning tests.
As expected, the distribution of quality of life and self-
rated health was significantly related to cognitive func-
tion in both sexes. The proportion of the subjects who
rated their quality of life and self-rated health as good or
very good was lower in the group with lowered cognitive
function than in the group with normal cognitive func-
tion. Other health conditions are differently related tocognitive functioning. The subjects with lowered cogni-
tive function reported an increased frequency of previ-
ous stroke as compared to the subjects with normal
cognitive function. The prevalence of IHD was signifi-
cantly higher in men with lowered cognitive function
than in men with normal cognitive function, yet the dif-
ference in women group was not significant enough.
Diabetes, metabolic syndrome and hypertension were
not related to cognitive functioning. People who better
performed during cognitive function tests had less de-
pressive symptoms than people with poorer cognitive
functions.
Further, variables significantly related to cognitive
functioning in univariate analysis were put into the mul-
tivariable analysis. Table 3 shows the multivariable odds
ratios (ORs) for lowered cognitive function. In both
sexes, individuals with previous stroke had significantly
higher odds of lowered cognitive function compared to
those without stroke: 2.52 times higher among men and
2.45 times higher among women. In men, the individuals
with IHD had higher ORs of lowered cognitive function
as compared to the men without IHD. The individuals
who rated their quality of life as very poor and poor
were more likely to demonstrate lowered cognitive per-
formance compared to those who rated their quality of
life as very good and good. The men who rated their
health as good and very good were more likely to have
better cognitive functions than the men who thought
that their health was very poor or poor. This association
was not significant for women though. For women,
physical inactivity in leisure time was related with higher
ORs of lowered cognitive function.
Discussion
To the best of our knowledge, the presented results are
the first estimates of the cognitive function and its
Table 2 Age-adjusted means (± SE)a and distribution of variables (%) according to the cognitive function
Variables Men (n = 3,129) Women (n = 3,775)
Cognitive function Cognitive function
Lowered (n = 645) Normal (n = 2,484) Lowered (n = 444) Normal (n = 3,331)
Age, years 61.0 ± 0.3 60.4 ± 0.15 60.4 ± 0.35 60.3 ± 0.13
Deprivationa, score 4.76 ± 0.02 4.79 ± 0.01 4.51 ± 0.03 4.59 ± 0.01*
Crowdinga, absolute number 2.69 ± 0.05 2.69 ± 0.02 2.35 ± 0.06 2.36 ± 0.02
Systolic blood pressurea, mm Hg 148.3 ± 0.84 146.1 ± 0.43* 138.1 ± 0.97 137.2 ± 0.35
Diastolic blood pressurea, mm Hg 93.8 ± 0.5 92.7 ± 0.25* 88.7 ± 0.56 88.3 ± 0.2
Total cholesterola, mmol/L 5.73 ± 0.02 5.78 ± 0.02 6.07 ± 0.05 6.13 ± 0.02
HDL cholesterola, mmol/L 1.39 ± 0.02 1.4 ± 0.01 1.52 ± 0.02 1.58 ± 0.01**
LDL cholesterola, mmol/L 3.65 ± 0.04 3.71 ± 0.02 3.86 ± 0.05 3.89 ± 0.02
Triglyceridea, mmolL 1.53 ± 0.04 1.47 ± 0.02 1.54 ± 0.04 1.45 ± 0.02*
Fasting blood glucosea, mmol/L 5.77 ± 0.05 5.84 ± 0.03 5.94 ± 0.06 5.84 ± 0.02
Body mass indexa, kg/m2 28.6 ± 0.18 28.5 ± 0.09 30.2 ± 0.27 30.1 ± 0.10
Physical activity in leisure timea, hours/week 16.4 ± 0.49 17.7 ± 0.25* 18.1 ± 0.56 20.1 ± 0.2*
Absolute alcohol a, drinks/week 57.6 ± 4.6 56.6 ± 2.31 14.6 ± 1.41 17.8 ± 0.51*
Ischemic heart disease (%) χ2 = 12.7; p < 0.001 χ2 = 0.21; p > 0.05
Yes 22.9 16.9 20.5 19.6
No 77.1 83.1 79.5 80.4
Stroke (%) χ2 = 42.1; p < 0.001 χ2 = 26.5; p < 0.001
Yes 9.0 3.1 8.2 3.2
No 91.0 96.9 91.8 99.8
Diabetes mellitus (%) χ2 = 0.02; p > 0.05 χ2 = 0.61, p > 0.05
Yes 8.8 8.6 10.4 9.2
No 91.2 91.4 89.6 90.8
Metabolic syndrome (%) χ2 = 0.00; p > 0.05 χ2 = 3.5; p > 0.05
Yes 29.3 29.4 43.2 38.5
No 70.7 70.6 56.8 61.5
Arterial hypertension (%) χ2 = 0.69; p > 0.05 χ2 = 0.83; p > 0.05
Yes 75.3 73.7 56.8 61.5
No 24.7 26.3 43.2 38.5
Body mass index, (%) χ2 = 3.44; p > 0.05 χ2 = 3.92; p > 0.05
<18.5 kg/m2 0.5 0.2 0.5 0.3
18.5- 24.99 kg/m2 21.4 21.9 18.7 19.0
25.0-29.9 kg/m2 41.7 44.6 31.5 35.7
> = 30.0 kg/m2 36.4 33.3 49.3 45.0
Smoking habits (%) χ2 = 0.33; p > 0.05 χ2 = 0.71; p > 0.05
Smokers 30.4 30.6 11.0 9.7
Former smokers 30.1 31.1 7.1 7.3
Never smokers 39.5 38.3 81.9 83.0
Marital status (%) χ2 = 8.32; p > 0.05 χ2 = 5.86; p > 0.05
Single 1.4 2.0 7.3 5.4
Married 80.7 84.3 52.2 56.9
Cohabiting 2.4 1.4 0.5 0.9
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Table 2 Age-adjusted means (± SE)a and distribution of variables (%) according to the cognitive function (Continued)
Divorced 9.2 7.2 17.6 15.9
Widowed 6.3 5.1 22.4 20.9
Quality of life (%) χ2 = 14.4; p < 0.01 χ2 = 37.3; p < 0.001
Very poor and poor 5.5 2.9 10.4 4.0
Average 49.2 47.1 51.1 50.2
Good 43.1 48.2 37.1 44.5
Very good 2.2 1.8 1.4 1.3
Self-rated health (%) χ2 = 23.6; p < 0.001 χ2 = 17.6; p < 0.001
Very good and good 26.8 34.4 16.9 21.5
Average 57.5 55.6 58.7 61.8
Poor and very poor 15.7 10.0 24.4 16.7
Depression scale score (%) χ2 = 7.28; p < 0.01 χ2 = 12.8; p < 0.001
> = 4 18.9 14.5 37.0 28.7
<4 81.1 85.5 63.0 71.3
a age-adjusted means and standard errors.
SE – standard error.
HDL – high density lipoprotein.
LDL – low density lipoprotein.
* p < 0.05; ** p < 0.01; as compared to lowered cognitive function group (means were compared using t test).
Table 3 Multivariable adjusted odds ratios (ORs) and 95%
confidence intervals (CI) for lowered cognitive function*
Variables Men Women
OR (95% CI) OR (95% CI)
Stroke 2.52 (1.75-3.64) 2.45 (1.64-3.66)
Ischemic heart disease 1.28 (1.03-1.60) n.s.
Quality of life
Very good and good 1.0 1.0
Neither poor nor good 1.03 (0.86-1.24) 1.16 (0.94-1.44)
Very poor and poor 1.67 (1.07-2.61) 2.81 (1.92-4.11)
Self-rated health
Good and very good 1.0 n.s.
Average 1.21 (0.99-1.50)
Poor and very poor 1.57 (1.15-2.14)
Diastolic blood pressure, mm Hg 1.01 (1.00-1.01) n.s.
Physical activity in leisure time
3rd tertile (> 22.5 hours/week) 1.0
2nd tertile (14.1-22.5 hours/week) n.s. 1.14 (0.88-1.49)
1st tertile (0.0-14.0 hours/week) 1.32 (1.03-1.69)
*- 1 SD or more below age and education specific mean of the composite
score of cognitive function.
n.s. – not significant.
In men, ORs are adjusted for previous stroke, ischemic heart disease, quality of
life, self-rated health, diastolic blood pressure, physical activity in leisure time,
and depression scale score.
In women, ORs are adjusted for previous stroke, quality of life, self-rated
health, HDL cholesterol, triglycerides, physical activity in leisure time, alcohol
intake, and depression scale score.
Variable selection was conducted by a stepwise backward procedure using the
likelihood ratio criterion.
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large group of general middle-aged and elderly urban
population in Lithuania that were obtained using inter-
nationally accepted battery of five standard tasks. This
study confirmed the association between older age,
lower education level and poorer cognitive performance
which had been proposed by previous studies [23-26].
Some gender differences were ascertained as well. In
general, women performed marginally better than men
on the global cognitive score, conversely to other studies
in such countries as Taiwan, Egypt, India or China [25-27].
These results can differ because of high educational
level of Lithuanian women. In our study, women
performed better on immediate and delayed verbal re-
call than men. These findings are similar to those of
the previous large longitudinal study carried out in
Netherlands [28]. Besides, most studies confirm that
women have advantages in memory tasks compared
to men [25-27,29].
The results of this study indicate that links between
cardiovascular risk factors and cognitive function are
mixed and highly dependent on gender. Stroke was an
independent predictor for lowered cognitive function.
This finding supports the results published in by other
studies [23,24,26,27]. The previous study suggests associ-
ation between coronary heart disease history and poorer
cognitive scores [3]. In the current study IHD also
showed a statistically significant association with lowered
cognitive function but among men only. This finding
could be explained by higher rates of cardiovascular dis-
ease among men in Lithuania [9,10]. It was suggested
that cardiovascular risk factors and diabetes, may also be
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current research similarly to some other studies found
no consistent associations [24,30]. Metabolic syndrome
was not related to poorer cognitive function as well.
Researchers in other studies came to a conclusion
that association between cognition, metabolic syn-
drome and its components depends on the specific
areas of cognition, which were not analyzed in this
study [30,31].
In contrast to the research which reported that hyper-
tension was associated with decreased cognitive function
and blood pressure was not [31], we found opposite
results. In general, the previous findings suggest very un-
certain connections between hypertension and cognition
[23,26,31]. Biomarkers were differently associated with
lowered cognitive function. Moreover, these associations
were confirmed only in univariate analyses. Which bio-
markers are related to cognition remains a controversial
issue [23,30,31]. Surprisingly, risk behaviors such as
smoking and alcohol drinking were not related to low-
ered cognition differently from the findings in the previ-
ous studies [10,11]. However, physical activity was
associated with better cognitive performance among
women, but not among men.
It had been argued that depressive symptoms regulate
association between cognitive functioning and cardiovas-
cular risk factors [2], yet our results indicated that the
relation between depressive symptoms and lowered cog-
nitive function was confirmed only in univariate analysis.
The implication is that cardiovascular risk factors affect
cognition independently. Besides, self-rated quality of life
in elderly is influenced by a poorer cognitive function
[32,33]. The current investigation revealed that a poor
quality of life was the most important predictor of a low-
ered cognitive function.
Limitations of our findings include the absence of
additional cognitive measures such as MMSE which
allowed us determine the prevalence of an impaired
cognitive function using the standard criteria and com-
pare the prevalence in other populations. Dementia
status was not controlled in our research as well.
Other limitations of our study include assessment of
cognitive function by random sample in Kaunas popu-
lation, but not on a nationally based measure. Add-
itionally, we used a cross-sectional design despite the
HAPIEE study is planned as cohort study. Although
incremental models were not analyzed in this research,
interactions of possible confounders will be discussed
in future studies.
Despite some limitations of the study it is the first
population based study in Lithuania which analyzed
associations between cognitive ability and various CVD
risk factors. This study reflects on biopsychosocial model
of health by analyzing cognitive functions in respect tomany different factors including clinical data as biomar-
kers, self-report measurements as depressive symptoms
and socio-demographic data.
Conclusions
This study adds to evidence that the prevalence of low-
ered cognitive function was significantly higher among
Lithuanian middle-aged and elderly urban men as com-
pared to women (20.6% and 11.8%). Previous stroke (in
both sexes), IHD and self-rated health (among men
only), were significantly associated with odds of lowered
cognitive function. Furthermore, the results from this
study indicate that physical activity in leisure time
(among women) and quality of life (in both sexes) are
related with cognitive performance.
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